TGM2 and myeloid sarcoma: Accumulating evidence from studies has identified the involvement of TG2 in postmortem MS brain samples and in the central nervous system of the animal model for experimental autoimmune encephalomyelitis (EAE), illustrating its role in the pathogenesis of MS [174,175,176,177,178].